MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: FOLFOX4 Therapieempfehlung

Raw json | Download

{
  "resourceType" : "RequestGroup",
  "id" : "mii-exa-onko-folfox-requestgroup-modification",
  "meta" : {
    "profile" : [
      🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-therapieempfehlung-kombinationstherapie|2027.0.0-ballot.1"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: RequestGroup mii-exa-onko-folfox-requestgroup-modification</b></p><a name=\"mii-exa-onko-folfox-requestgroup-modification\"> </a><a name=\"hcmii-exa-onko-folfox-requestgroup-modification\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-onko-therapieempfehlung-kombinationstherapie.html\">MII PR Onkologie Therapieempfehlung Kombinationstherapie</a> version: 2027.0.0-ballot.1</p></div><p><b>status</b>: Active</p><p><b>intent</b>: Proposal</p><p><b>code</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ CH}\">Chemotherapie</span></p><p><b>subject</b>: <a href=\"Patient-example-modification.html\">Martin Beispiel  Male, DoB: 1958-11-03</a></p><p><b>authoredOn</b>: 2024-03-05</p><p><b>reasonReference</b>: <a href=\"Condition-mii-exa-onko-ascending-colon-cancer-diagnosis.html\">Condition Bösartige Neubildung: Colon ascendens</a></p><blockquote><p><b>action</b></p><p><b>title</b>: FOLFOX4 Protocol</p><p><b>description</b>: FOLFOX4 chemotherapy protocol: Fluorouracil + Folinsäure + Oxaliplatin, 12 cycles planned</p><p><b>code</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-protokolle FOLFOX4}\">FOLFOX4</span></p><h3>Actions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Title</b></td><td><b>Description</b></td><td><b>Resource</b></td></tr><tr><td style=\"display: none\">*</td><td>Fluorouracil (5-FU)</td><td>5-Fluorouracil - pyrimidine analog</td><td><a href=\"MedicationRequest-mii-exa-onko-modification-5fu-request.html\">MedicationRequest: status = completed; intent = proposal; medication[x] = Fluorouracil; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles</a></td></tr><tr><td style=\"display: none\">*</td><td>Folinsäure (Leucovorin)</td><td>Folinic acid - enhances 5-FU efficacy</td><td><a href=\"MedicationRequest-mii-exa-onko-modification-leucovorin-request.html\">MedicationRequest: status = completed; intent = proposal; medication[x] = Calciumfolinat; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles</a></td></tr><tr><td style=\"display: none\">*</td><td>Oxaliplatin</td><td>Platinum-based chemotherapy agent</td><td><a href=\"MedicationRequest-mii-exa-onko-modification-oxaliplatin-request.html\">MedicationRequest: status = stopped; statusReason = Adverse reaction (disorder); intent = proposal; medication[x] = Oxaliplatin; authoredOn = 2024-03-05; note = Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity.</a></td></tr></table></blockquote></div>"
  },
  "status" : "active",
  "intent" : "proposal",
  "code" : {
    "coding" : [
      {
        "system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
        "code" : "CH",
        "display" : "Chemotherapie"
      }
    ],
    "text" : "Chemotherapie"
  },
  "subject" : {
    🔗 "reference" : "Patient/example-modification"
  },
  "authoredOn" : "2024-03-05",
  "reasonReference" : [
    {
      🔗 "reference" : "Condition/mii-exa-onko-ascending-colon-cancer-diagnosis"
    }
  ],
  "action" : [
    {
      "title" : "FOLFOX4 Protocol",
      "description" : "FOLFOX4 chemotherapy protocol: Fluorouracil + Folinsäure + Oxaliplatin, 12 cycles planned",
      "code" : [
        {
          "coding" : [
            {
              "system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-protokolle",
              "code" : "FOLFOX4",
              "display" : "FOLFOX4"
            }
          ]
        }
      ],
      "action" : [
        {
          "title" : "Fluorouracil (5-FU)",
          "description" : "5-Fluorouracil - pyrimidine analog",
          "resource" : {
            🔗 "reference" : "MedicationRequest/mii-exa-onko-modification-5fu-request"
          }
        },
        {
          "title" : "Folinsäure (Leucovorin)",
          "description" : "Folinic acid - enhances 5-FU efficacy",
          "resource" : {
            🔗 "reference" : "MedicationRequest/mii-exa-onko-modification-leucovorin-request"
          }
        },
        {
          "title" : "Oxaliplatin",
          "description" : "Platinum-based chemotherapy agent",
          "resource" : {
            🔗 "reference" : "MedicationRequest/mii-exa-onko-modification-oxaliplatin-request"
          }
        }
      ]
    }
  ]
}